Last reviewed · How we verify
Loteprednol etabonate 0.5% and tobramycin 0.3%
Loteprednol etabonate 0.5% and tobramycin 0.3% is a Small molecule drug developed by Bausch & Lomb Incorporated. It is currently FDA-approved. Also known as: Zylet.
At a glance
| Generic name | Loteprednol etabonate 0.5% and tobramycin 0.3% |
|---|---|
| Also known as | Zylet |
| Sponsor | Bausch & Lomb Incorporated |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis Trial (PHASE1)
- A Novel Combined Therapy for Refractory Vernal Keratoconjunctivitis (PHASE4)
- Zylet vs TobraDex in Blepharokeratoconjunctivitis (PHASE4)
- Ocular Tolerance and Intraocular Pressure (IOP) Effects of Zylet Versus Tobradex (PHASE4)
- Pediatric Zylet Safety and Efficacy Study (PHASE4)
- A Retrospective Evaluation of the Intraocular Pressure Spikes With Loteprednol and Loteprednol/Tobramycin
- Intraocular Pressure With Loteprednol and Dexamethasone (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Loteprednol etabonate 0.5% and tobramycin 0.3% CI brief — competitive landscape report
- Loteprednol etabonate 0.5% and tobramycin 0.3% updates RSS · CI watch RSS
- Bausch & Lomb Incorporated portfolio CI
Frequently asked questions about Loteprednol etabonate 0.5% and tobramycin 0.3%
What is Loteprednol etabonate 0.5% and tobramycin 0.3%?
Loteprednol etabonate 0.5% and tobramycin 0.3% is a Small molecule drug developed by Bausch & Lomb Incorporated.
Who makes Loteprednol etabonate 0.5% and tobramycin 0.3%?
Loteprednol etabonate 0.5% and tobramycin 0.3% is developed and marketed by Bausch & Lomb Incorporated (see full Bausch & Lomb Incorporated pipeline at /company/bausch-lomb-incorporated).
Is Loteprednol etabonate 0.5% and tobramycin 0.3% also known as anything else?
Loteprednol etabonate 0.5% and tobramycin 0.3% is also known as Zylet.
What development phase is Loteprednol etabonate 0.5% and tobramycin 0.3% in?
Loteprednol etabonate 0.5% and tobramycin 0.3% is FDA-approved (marketed).
Related
- Manufacturer: Bausch & Lomb Incorporated — full pipeline
- Also known as: Zylet
- Compare: Loteprednol etabonate 0.5% and tobramycin 0.3% vs similar drugs
- Pricing: Loteprednol etabonate 0.5% and tobramycin 0.3% cost, discount & access